Marc Thill

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study

Luca Gianni, Chiun‐Sheng Huang, Daniel Egle et al. · Annals of Oncology · 2022 · 386 citations · Full text

Medicine, Oncology, Pharmacology +15

Spatial predictors of immunotherapy response in triple-negative breast cancer

Xiao Qian Wang, Esther Danenberg, Chiun‐Sheng Huang et al. · Nature · 2023 · 325 citations · Full text

Medicine, Immunology, Oncology +17

Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial

Toralf Reimer, Angrit Stachs, Kristina Veselinovic et al. · New England Journal of Medicine · 2024 · 248 citations

Medicine, Oncology, Surgery +16

The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope

Marc Thill, Andrzej Kurylcio, Rebekka Welter et al. · The Breast · 2014 · 197 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016

Cornelia Liedtke, Marc Thill · Breast Care · 2016 · 190 citations · Full text

Medicine, Oncology, Pathology +16